A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer

Figure 2

Association of KMT2 gene expression with patient overall survival for different cancer types. The forest plots with the hazard ratios and 95% confidence intervals for overall survival for different cancer types to show survival advantage and disadvantage with increased gene expression of KMT2 family. Univariate Cox proportional hazard regression models were used for the association tests.